Jie-Lin Wang
Research Subjects
Jie-Lin Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jing Li
Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
2 shared publications - Ping-An Zhang
National Clinical Research Center for Respiratory Disease The First Affiliated Hospital of Guangzhou Medical University Guangzhou China
2 shared publications - Rundong Qin
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Department of Allergy and Clinical Immunology, The First Affiliated Hospital of Guangzhou Medical University, 151, Yanjiangxi Rd, Guangzhou, Guangdong, 510120, China
2 shared publications Hua-Lian Luo
State Key Laboratory of Respiratory Disease , National Clinical Research Center for Respiratory Disease , Guangzhou Institute of Respiratory Health , Department of Allergy and Clinical Immunology , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , Guangdong , China , gzhmc.edu.cn
1 shared publicationJing Liu
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Department of Allergy and Clinical Immunology, The First Affiliated Hospital of Guangzhou Medical University , 151 Yanjiangxi Rd, Guangzhou, Guangdong 510120
1 shared publication- Mei-Hua Dong
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Department of Allergy and Clinical Immunology, The First Affiliated Hospital of Guangzhou Medical University , 151 Yanjiangxi Rd, Guangzhou, Guangdong 510120
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (2)
A causal glycerophospholipid–IL-18R1–CD9 axis connects lipid metabolism and T-cell activation in atopic dermatitis
Atopic dermatitis (AD) involves complex metabolic–immune dysregulation, but the molecular links remain unclear. This study integrates a multilevel analytical framework to systematically investigate the metabolic–immune crosstalk in AD. Using linkage disequilibrium score regression and a two-step Mendelian randomization approach, we established genetic correlations and inferred causal relationships between plasma metabolites and inflammatory proteins, identifying 1-palmitoyl-2-arachidonoyl-GPC (PA-GPC) as a protective metabolite that exerts its effect primarily through downregulation of interleukin-18 receptor 1 (IL-18R1). Integration of single-cell transcriptomic data further revealed elevated IL-18R1 expression in T cells within the AD microenvironment and enabled stratification of T cells based on PA-GPC–associated metabolic activity, identifying 33 differentially expressed genes. Subsequent least absolute shrinkage and selection operator (LASSO) regression, combined with machine learning models and SHapley Additive exPlanations analysis, consistently prioritized CD9 as a key regulator. Functional validation showed that PA-GPC attenuates tumor necrosis factor-alpha (TNF-α)/interferon-gamma (IFN-γ)–induced inflammatory responses in human immortalized keratinocyte (HaCaT) cells and suppresses Th2 cytokine production in T cells. IL-18R1 knockdown reduced CD9 expression and Th2 cytokine production in T cells, whereas CD9 knockdown did not affect IL-18R1 expression, indicating that IL-18R1 acts upstream of CD9. Moreover, CD9 knockdown impaired T-cell viability, activation, and Th2 cytokine production. Collectively, these findings characterize metabolic–immune crosstalk in AD and identify a PA-GPC–IL-18R1–CD9 regulatory axis with potential therapeutic implications.
- 1 March 2026
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 27 (2)
Open AccessA causal glycerophospholipid–IL-18R1–CD9 axis connects lipid metabolism and T-cell activation in atopic dermatitis
Atopic dermatitis (AD) involves complex metabolic–immune dysregulation, but the molecular links remain unclear. This study integrates a multilevel analytical framework to systematically investigate the metabolic–immune crosstalk in AD. Using linkage disequilibrium score regression and a two-step Mendelian randomization approach, we established genetic correlations and inferred causal relationships between plasma metabolites and inflammatory proteins, identifying 1-palmitoyl-2-arachidonoyl-GPC (PA-GPC) as a protective metabolite that exerts its effect primarily through downregulation of interleukin-18 receptor 1 (IL-18R1). Integration of single-cell transcriptomic data further revealed elevated IL-18R1 expression in T cells within the AD microenvironment and enabled stratification of T cells based on PA-GPC–associated metabolic activity, identifying 33 differentially expressed genes. Subsequent least absolute shrinkage and selection operator (LASSO) regression, combined with machine learning models and SHapley Additive exPlanations analysis, consistently prioritized CD9 as a key regulator. Functional validation showed that PA-GPC attenuates tumor necrosis factor-alpha (TNF-α)/interferon-gamma (IFN-γ)–induced inflammatory responses in human immortalized keratinocyte (HaCaT) cells and suppresses Th2 cytokine production in T cells. IL-18R1 knockdown reduced CD9 expression and Th2 cytokine production in T cells, whereas CD9 knockdown did not affect IL-18R1 expression, indicating that IL-18R1 acts upstream of CD9. Moreover, CD9 knockdown impaired T-cell viability, activation, and Th2 cytokine production. Collectively, these findings characterize metabolic–immune crosstalk in AD and identify a PA-GPC–IL-18R1–CD9 regulatory axis with potential therapeutic implications.
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 5466012
Genetic Correlations and Causal Relationships Among Allergic Diseases: A Comprehensive Mendelian Randomization Study With Multiomic Mediation Analysis
Background: Allergic diseases, including allergic asthma (AA), allergic rhinitis (AR), atopic dermatitis (AD), and allergic conjunctivitis (AC), often coexist. However, the specific inflammatory mediators driving their shared mechanisms remain unclear. This study explored causal relationships and identified multiomic mediators among allergic diseases using Mendelian randomization (MR). Methods: Large‐scale GWAS datasets from FinnGen and UK Biobank were analyzed. Linkage disequilibrium score regression (LDSC) and MR–robust adjusted profile scoring (MR‐RAPS) assessed genetic correlations and causal links. Crucially, multivariable MR (MVMR) adjusted for classical type 2 inflammatory factors to isolate independent effects. A two‐step MR framework evaluated the mediating roles of immune cells, metabolites, gut microbiota, and serum proteins. Results: Six disease pairs (AA–AR, AA–AD, AR–AA, AR–AD, AD–AA, and AD–AR) showed robust causal relationships independent of type 2 inflammation markers. Mediation analyses identified key inflammatory mediators, including immune cell subsets (e.g., CD45 on granulocytes), plasma metabolites (e.g., pentose acid), gut microbiota (e.g., Bacteroides intestinalis ), and notably, serum proteins such as ABHD12 and SEZ6L2. Pathway analyses highlighted cytokine–cytokine receptor interactions and lipid metabolism. Conclusions: This study maps a comprehensive causal network of allergic multimorbidity. We identified novel serum proteins and metabolic mediators beyond the classical type 2 inflammation axis, offering potential therapeutic targets for disrupting the inflammatory crosstalk between allergic diseases.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 5466012
Open AccessGenetic Correlations and Causal Relationships Among Allergic Diseases: A Comprehensive Mendelian Randomization Study With Multiomic Mediation Analysis
Background: Allergic diseases, including allergic asthma (AA), allergic rhinitis (AR), atopic dermatitis (AD), and allergic conjunctivitis (AC), often coexist. However, the specific inflammatory mediators driving their shared mechanisms remain unclear. This study explored causal relationships and identified multiomic mediators among allergic diseases using Mendelian randomization (MR). Methods: Large‐scale GWAS datasets from FinnGen and UK Biobank were analyzed. Linkage disequilibrium score regression (LDSC) and MR–robust adjusted profile scoring (MR‐RAPS) assessed genetic correlations and causal links. Crucially, multivariable MR (MVMR) adjusted for classical type 2 inflammatory factors to isolate independent effects. A two‐step MR framework evaluated the mediating roles of immune cells, metabolites, gut microbiota, and serum proteins. Results: Six disease pairs (AA–AR, AA–AD, AR–AA, AR–AD, AD–AA, and AD–AR) showed robust causal relationships independent of type 2 inflammation markers. Mediation analyses identified key inflammatory mediators, including immune cell subsets (e.g., CD45 on granulocytes), plasma metabolites (e.g., pentose acid), gut microbiota (e.g., Bacteroides intestinalis ), and notably, serum proteins such as ABHD12 and SEZ6L2. Pathway analyses highlighted cytokine–cytokine receptor interactions and lipid metabolism. Conclusions: This study maps a comprehensive causal network of allergic multimorbidity. We identified novel serum proteins and metabolic mediators beyond the classical type 2 inflammation axis, offering potential therapeutic targets for disrupting the inflammatory crosstalk between allergic diseases.